Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

William Richards

Surgery Mobile, AL Medical Doctor

NPI 1548368491 CMS profile 206419

2451 University Hospital Dr, Mastin 101, Mobile, AL 36617

Open in the dashboard

General payments

$12,559

134 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$65,616 paid to institutions, not to them · program years 2022–2025

Through program year 2025, William Richards of Mobile, AL is reported in the CMS Open Payments database as having received $12,559 across 134 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $65,616 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 84th percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,772 14
2024 General $2,715 21
2023 General $1,548 23
2022 General $989 34
2021 General $417 12
2020 General $151 5
2019 General $3,967 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • William Richards
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to William Richards were reported at $2,772. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year William Richards Surgery median Middle half National median
2019 $3,967 $253 $82–$1,521 $163
2020 $151 $131 $40–$706 $114
2021 $417 $168 $50–$904 $132
2022 $989 $224 $76–$1,218 $149
2023 $1,548 $253 $82–$1,255 $160
2024 $2,715 $279 $90–$1,381 $164
2025 $2,772 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Intuitive Surgical, Inc. $6,122 68 payments
  2. Histosonics, Inc. $2,558 5 payments
  3. TELA Bio, Inc. $2,294 17 payments
  4. Davol Inc. $349 4 payments
  5. Standard Bariatrics, Inc. $222 10 payments
  6. Baxter Healthcare $149 6 payments
  7. Teleflex LLC $131 2 payments
  8. Ethicon US, LLC $121 2 payments
  9. Trevena, Inc. $81 4 payments
  10. Ambu Inc. $80 1 payment
  11. Other $452 15 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $7,346 15 payments
  2. Food and Beverage $5,048 115 payments
  3. Education $148 3 payments
  4. Gift $16 1 payment
Products named General payments · program years 2019–2025
  1. Da Vinci Surgical System $6,122 68 payments
  2. OviTex 2S $2,247 14 payments
  3. Phasix Mesh $349 4 payments
  4. TITAN SGS STANDARD GASTRIC STAPLER $222 10 payments
  5. TITAN SGS BAILOUT CHUCK $109 1 payment
  6. Echelon Circular $93 1 payment
  7. Echelon Flex $93 1 payment
  8. TISSEEL $89 4 payments
  9. OLINVYK $81 4 payments
  10. XCM BIOLOGIC $51 1 payment
  11. Other $484 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for General Surgery: 59

Drug cost

$159

Median for General Surgery: $393

Branded share of claims

100%

Median for General Surgery: 28.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Sodium Chloride Sodium Chloride 0.45 % Brand 14 $159

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 15,891 Part D prescribers listed as General Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$26,465

Medicare's payments for the services billed

Medicare patients

33

Average age 69

Services billed

90

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 58%
Chronic kidney disease 52%
Depression 45%
Ischemic heart disease 39%
COPD 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

134 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Alabama

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record